重启IPO：一家医疗器械公司20年长跑与资本化抉择

Core Viewpoint - Zhejiang Zhengya Dental Co., Ltd. is restarting its IPO process, reflecting not only the company's capital strategy adjustment but also providing a case worth observing in the medical device sector [2] Company Overview - Established on December 28, 2010, Zhengya Dental has a registered capital of 360,000 yuan and is headquartered in Jiaxing, Zhejiang Province [3] - The founder, Yao Junfeng, holds approximately 39.57% of the company's shares, indicating strong control over strategic decisions [7] Historical Context - Zhengya Dental's history dates back to October 2004, when it was registered as Zhengya Dental Technology (Shanghai) Co., Ltd., making it a company with over 20 years of experience in the dental medical device industry [5] - The company underwent nearly ten years of early technical accumulation before receiving angel round financing in 2013, which is atypical in the fast-paced startup environment [6] Manufacturing Capabilities - Zhengya Dental is the only domestic company that achieves full-process self-production of invisible orthodontic products, from polymer raw material extrusion to finished products [9] - The new production base in Jiaxing, set to be operational by October 2024, will cover 100,000 square meters and house over 180 industrial-grade 3D printing devices, with an expected annual output of over 10 million orthodontic devices by 2025 [9][10] Product Differentiation - The company has developed a comprehensive product system that addresses various orthodontic needs, including a unique "jaw position reconstruction technology" aimed at complex cases [12][13] - Zhengya has partnered with Disney and Marvel to create orthodontic products for children, targeting the growing early intervention market [14] Financing History - Zhengya Dental's financing history includes multiple rounds, starting from angel investment in 2013 to a significant D round in March 2022, raising 500 million yuan led by Taikang Investment [16] - The diverse investor base includes industry capital, top-tier PE/VC, insurance capital, and state-owned funds, indicating strong market confidence [16][17] IPO Advisory Changes - The company has switched its IPO sponsor from CICC to CITIC Securities, a move seen as more practical given the current IPO environment and CITIC's strong track record in the medical device sector [18] Industry Trends - Zhengya's IPO restart is part of a broader trend in the dental medical sector, with several companies accelerating their capital processes amid increasing competition [19] - The invisible orthodontics segment faces unique challenges due to regulatory requirements and market competition, which may complicate the IPO review process [20] Strategic Insights - Key strategic themes for Zhengya include "manufacturing depth," "globalization," and "timing," highlighting the importance of a self-controlled manufacturing system, international market expansion, and capitalizing on current market conditions [21][22]